These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Epigenetic and post-transcriptional dysregulation of gene expression in schizophrenia and related disease. Gavin DP; Akbarian S Neurobiol Dis; 2012 May; 46(2):255-62. PubMed ID: 22182689 [TBL] [Abstract][Full Text] [Related]
5. Evidence for microRNA-mediated regulation in rheumatic diseases. Luo X; Tsai LM; Shen N; Yu D Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i30-36. PubMed ID: 19995741 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA and Posttranscriptional Dysregulation in Psychiatry. Geaghan M; Cairns MJ Biol Psychiatry; 2015 Aug; 78(4):231-9. PubMed ID: 25636176 [TBL] [Abstract][Full Text] [Related]
7. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease. Kaucsár T; Rácz Z; Hamar P Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025 [TBL] [Abstract][Full Text] [Related]
8. Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells. Gardiner E; Beveridge NJ; Wu JQ; Carr V; Scott RJ; Tooney PA; Cairns MJ Mol Psychiatry; 2012 Jul; 17(8):827-40. PubMed ID: 21727898 [TBL] [Abstract][Full Text] [Related]
10. A complex crosstalk between polymorphic microRNA target sites and AD prognosis. Mallick B; Ghosh Z RNA Biol; 2011; 8(4):665-73. PubMed ID: 21659796 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA networks alter to conform to transcription factor networks adding redundancy and reducing the repertoire of target genes for coordinated regulation. Iwama H; Murao K; Imachi H; Ishida T Mol Biol Evol; 2011 Jan; 28(1):639-46. PubMed ID: 20805189 [TBL] [Abstract][Full Text] [Related]
12. microRNAs in neurons: manifold regulatory roles at the synapse. Siegel G; Saba R; Schratt G Curr Opin Genet Dev; 2011 Aug; 21(4):491-7. PubMed ID: 21561760 [TBL] [Abstract][Full Text] [Related]
13. Brain expressed microRNAs implicated in schizophrenia etiology. Hansen T; Olsen L; Lindow M; Jakobsen KD; Ullum H; Jonsson E; Andreassen OA; Djurovic S; Melle I; Agartz I; Hall H; Timm S; Wang AG; Werge T PLoS One; 2007 Sep; 2(9):e873. PubMed ID: 17849003 [TBL] [Abstract][Full Text] [Related]
14. Targeting microRNAs in neurons: tools and perspectives. Ruberti F; Barbato C; Cogoni C Exp Neurol; 2012 Jun; 235(2):419-26. PubMed ID: 22085592 [TBL] [Abstract][Full Text] [Related]
16. Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease. Georges M; Coppieters W; Charlier C Curr Opin Genet Dev; 2007 Jun; 17(3):166-76. PubMed ID: 17467975 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA and aging: a novel modulator in regulating the aging network. Chen LH; Chiou GY; Chen YW; Li HY; Chiou SH Ageing Res Rev; 2010 Nov; 9 Suppl 1():S59-66. PubMed ID: 20708718 [TBL] [Abstract][Full Text] [Related]
18. The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? Eastwood SL Int Rev Neurobiol; 2004; 59():47-72. PubMed ID: 15006484 [TBL] [Abstract][Full Text] [Related]
20. Gene silencing in vitro and in vivo using intronic microRNAs. Lin SL; Ying SY Methods Mol Biol; 2006; 342():295-312. PubMed ID: 16957384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]